Your browser is no longer supported. Please, upgrade your browser.
Settings
AMAG AMAG Pharmaceuticals, Inc. daily Stock Chart
AMAG [NASD]
AMAG Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-8.41 Insider Own0.20% Shs Outstand34.30M Perf Week-0.56%
Market Cap367.35M Forward P/E- EPS next Y-1.53 Insider Trans- Shs Float33.40M Perf Month15.16%
Income-287.30M PEG- EPS next Q-0.46 Inst Own- Short Float42.35% Perf Quarter-9.47%
Sales326.20M P/S1.13 EPS this Y22.80% Inst Trans6.85% Short Ratio17.54 Perf Half Y10.98%
Book/sh14.18 P/B0.76 EPS next Y42.50% ROA-27.30% Target Price10.75 Perf Year-43.03%
Cash/sh5.58 P/C1.92 EPS next 5Y- ROE-49.30% 52W Range6.81 - 18.39 Perf YTD-29.49%
Dividend- P/FCF- EPS past 5Y-61.90% ROI-11.90% 52W High-41.76% Beta0.36
Dividend %- Quick Ratio1.50 Sales past 5Y42.40% Gross Margin71.60% 52W Low57.27% ATR0.64
Employees467 Current Ratio1.70 Sales Q/Q-31.20% Oper. Margin-82.90% RSI (14)52.76 Volatility3.73% 5.06%
OptionableYes Debt/Eq0.57 EPS Q/Q62.90% Profit Margin-88.50% Rel Volume0.75 Prev Close10.70
ShortableYes LT Debt/Eq0.57 EarningsNov 01 BMO Payout- Avg Volume806.62K Price10.71
Recom3.00 SMA207.14% SMA50-0.74% SMA200-3.11% Volume602,375 Change0.09%
Oct-30-19Downgrade Piper Jaffray Neutral → Underweight $9 → $6
Aug-01-19Initiated H.C. Wainwright Buy $16
Jun-11-19Initiated Barclays Overweight $19
Mar-20-19Initiated SunTrust Hold
Dec-14-18Reiterated B. Riley FBR Buy $29 → $20.50
Nov-06-18Downgrade JP Morgan Neutral → Underweight
Jun-15-18Downgrade Janney Buy → Neutral
May-21-18Resumed Leerink Partners Mkt Perform
Mar-14-18Reiterated B. Riley FBR, Inc. Neutral $16 → $23
Feb-15-18Upgrade Janney Neutral → Buy
Dec-07-17Initiated B. Riley FBR, Inc. Neutral $16
Oct-23-17Initiated Piper Jaffray Neutral $18
Sep-08-17Initiated Morgan Stanley Overweight $26
Jan-11-17Downgrade Needham Buy → Hold
Jan-10-17Downgrade Leerink Partners Outperform → Mkt Perform
Jan-09-17Downgrade Raymond James Mkt Perform → Underperform
Oct-27-16Initiated Needham Buy $40
May-09-16Reiterated Deutsche Bank Hold $42 → $35
May-04-16Downgrade Raymond James Outperform → Mkt Perform
Jan-21-16Initiated Barclays Equal Weight $32
Dec-02-19 08:20AM  Those Who Purchased AMAG Pharmaceuticals (NASDAQ:AMAG) Shares Five Years Ago Have A 74% Loss To Show For It Simply Wall St.
Dec-01-19 09:30AM  Why Is AMAG Pharmaceuticals (AMAG) Up 9.7% Since Last Earnings Report? Zacks
Nov-26-19 09:19AM  Is the Options Market Predicting a Spike in AMAG Pharmaceuticals (AMAG) Stock? Zacks
Nov-19-19 04:54PM  Teva, Bausch Could Be Next to File for Bankruptcy GuruFocus.com
Nov-16-19 08:18AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG ACCESSWIRE
Nov-13-19 02:14PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG GlobeNewswire +5.21%
08:00AM  AMAG Pharmaceuticals to Present at Upcoming Investor Conferences GlobeNewswire
Nov-07-19 05:44PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG GlobeNewswire
11:44AM  Hedge Funds Are Still Bullish On AMAG Pharmaceuticals (AMAG) Insider Monkey
Nov-06-19 06:18AM  AMAG Sees Hammer Chart Pattern: Time to Buy? Zacks
Nov-05-19 03:35AM  Edited Transcript of AMAG earnings conference call or presentation 1-Nov-19 12:00pm GMT Thomson Reuters StreetEvents
Nov-04-19 11:18AM  AMAG Q3 Loss Wider Than Expected, Revenues Lag Estimates Zacks -5.84%
Nov-01-19 12:25PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. - AMAG GlobeNewswire
09:15AM  AMAG Pharmaceuticals (AMAG) Reports Q3 Loss, Lags Revenue Estimates Zacks
07:00AM  AMAG Pharmaceuticals Announces Third Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Oct-31-19 11:36AM  The Zacks Analyst Blog Highlights: Alexion, Amgen, Gilead and AMAG Zacks -6.23%
10:55AM  Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. (AMAG) ACCESSWIRE
Oct-30-19 04:23PM  Biotech Dives After Panel Votes To Pull Its Drug Following Failed Test Investor's Business Daily -22.36%
10:56AM  Biotech Stock Roundup: Q3 Earnings Beat at ALXN & AMGN, Pipeline Updates & More Zacks
10:15AM  What's in Store for GW Pharmaceuticals (GWPH) in Q3 Earnings? Zacks
09:20AM  AMAG Pharmaceuticals Falls 25% After FDA Recommends Removing Makena From The Market Benzinga
Oct-29-19 09:40PM  AMAG Reports on FDA Advisory Committee Meeting for Makena® (Hydroxyprogesterone Caproate Injection) GlobeNewswire
05:05PM  FDA committee votes to pull labor-halting drug from market American City Business Journals
10:29AM  AMAG Pharmaceuticals, Inc. (AMAG) Shares March Higher, Can It Continue? Zacks
10:25AM  Is a Beat in Store for Amarin (AMRN) This Earnings Season? Zacks
07:03AM  AMAG Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee Meeting to Discuss the Results of the Makena PROLONG Trial GlobeNewswire
Oct-28-19 04:21PM  This Biotech Stock Popped But Could The FDA Pull Its Key Drug? Investor's Business Daily +8.73%
06:04AM  Proxy fights reach 'frightening' level in life sciences, other industries, top attorney says American City Business Journals
Oct-27-19 12:56PM  The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings Benzinga
Oct-25-19 10:30AM  AMAG Pharmaceuticals (AMAG) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks +13.83%
10:19AM  AMAG Pharmaceuticals Announces the Publication of the PROLONG Trial Evaluating 17-OHPC in the American Journal of Perinatology GlobeNewswire
Oct-24-19 08:00AM  AMAG Pharmaceuticals to Host Third Quarter 2019 Financial Results Conference Call and Webcast on Friday, November 1, 2019 at 8:00 a.m. ET GlobeNewswire -9.27%
Oct-11-19 08:00AM  AMAG Pharmaceuticals Announces the Publication of the Phase 3 Vyleesi (Bremelanotide Injection) Data in Obstetrics & Gynecology GlobeNewswire
Oct-08-19 08:45AM  UPDATE 2-Amag settles with activist Caligan, adds two board directors Reuters
08:14AM  Amag appoints activist investor Caligan's nominees to board Reuters
08:00AM  AMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP GlobeNewswire
Sep-28-19 09:05AM  Here's Why AMAG Pharmaceuticals (NASDAQ:AMAG) Can Afford Some Debt Simply Wall St.
Sep-26-19 08:00AM  Caligan Partners Issues Letter to AMAG Shareholders Business Wire -5.42%
Sep-25-19 08:00AM  AMAG Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire
Sep-23-19 08:00AM  AMAG Files Definitive Consent Revocation Statement and Sends Letter to Shareholders GlobeNewswire
Sep-20-19 08:44AM  UPDATE 2-Camber Capital to discuss Amag's board composition with shareholders Reuters +8.54%
08:20AM  Camber Capital says Amag Pharma's shares undervalued, seeks changes Reuters
Sep-16-19 08:00AM  Caligan Partners Launches Consent Solicitation Process and Sends Letter to AMAG Shareholders Business Wire
Sep-12-19 08:00AM  AMAG Sends Letter to Shareholders GlobeNewswire
Sep-06-19 09:31AM  Why Is AMAG Pharmaceuticals (AMAG) Up 27.3% Since Last Earnings Report? Zacks
Sep-05-19 06:24AM  Activist investor pushes for ex-Goop CEO, others to join board of Waltham drugmaker Amag American City Business Journals
Sep-04-19 05:56PM  AMAG Urges Stockholders to Take No Action on Caligan Partners Consent Solicitation Materials GlobeNewswire +8.19%
09:45AM  Activist Investor Seek Four Board Seats at Amag Pharmaceuticals Bloomberg
Aug-30-19 09:29PM  Edited Transcript of AMAG earnings conference call or presentation 7-Aug-19 12:00pm GMT Thomson Reuters StreetEvents
Aug-27-19 08:00AM  AMAG Pharmaceuticals Announces Commercial Availability of Vyleesi (Bremelanotide Injection) GlobeNewswire
Aug-20-19 08:00AM  AMAG Pharmaceuticals Announces Grant of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Aug-16-19 10:42AM  Palatin's (PTN) to Report Q4 Earnings: What's in the Cards? Zacks
06:20AM  Gene therapies to test FDA's approach to regulating drugs after launch, experts say American City Business Journals
Aug-15-19 02:23PM  [video]New York Investment Firm Discloses 10.3% Amag Stake, May Propose Changes TheStreet.com -6.25%
Aug-14-19 01:39PM  Have Insiders Been Buying AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Shares? Simply Wall St.
Aug-13-19 11:42AM  Jim Cramer Shares His Thoughts On Delta Air Lines, Okta And More Benzinga
08:00AM  AMAG PHARMACEUTICALS ANNOUNCES GRANT OF INDUCEMENT AWARDS UNDER NASDAQ LISTING RULE 5635(c)(4) GlobeNewswire
Aug-12-19 04:00PM  Why AMAG Pharmaceuticals Stock Jumped Today Motley Fool +14.19%
Aug-09-19 09:41AM  AMAG Pharmaceuticals Inc (AMAG) Q2 2019 Earnings Call Transcript Motley Fool +11.52%
Aug-08-19 11:20AM  AMAG Q2 Loss Widens, Sales Lag Estimates, 2019 Guidance Cut Zacks +5.09%
Aug-07-19 03:00PM  What's Behind AMAG Pharmaceuticals' Horrible Q2 Results Motley Fool -9.05%
08:35AM  AMAG Pharmaceuticals (AMAG) Reports Q2 Loss, Misses Revenue Estimates Zacks
07:00AM  AMAG Pharmaceuticals Announces Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Aug-06-19 12:50PM  UPDATE 1-Amag's female libido injectable therapy to sell at $899 Reuters +9.21%
12:43PM  Amag's female libido injectable therapy to sell at $899 Reuters
12:21PM  Amag's female libido injectable therapy to sell at $899 Reuters
Jul-31-19 10:36AM  AMAG Pharmaceuticals (AMAG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jul-29-19 08:00AM  AMAG Pharmaceuticals to Host Second Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, August 7, 2019 at 8:00 a.m. ET GlobeNewswire
Jul-25-19 10:33AM  Will AMAG Pharmaceuticals (AMAG) Report Negative Q2 Earnings? What You Should Know Zacks
Jul-23-19 09:29AM  AMAG (AMAG) to Report Q2 Earnings: What's in the Cards? Zacks
Jul-09-19 03:07PM  Calculating The Intrinsic Value Of AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) Simply Wall St.
Jul-04-19 08:35AM  Alexion's Ultomiris Receives EU Approval for PNH in Adults Zacks
Jun-28-19 01:03PM  Largest Insider Trades of the Week GuruFocus.com
Jun-27-19 12:55PM  Heres What Hedge Funds Think About AMAG Pharmaceuticals, Inc. (AMAG) Insider Monkey
Jun-26-19 08:37AM  Biotech Stock Roundup: Vertex, AMAG Drugs Get FDA Nod, Conatus Study Fails & More Zacks
Jun-25-19 03:49PM  Why Palatin Technologies Stock Dropped as Much as 21.5% Today Motley Fool
02:00PM  How Raleigh's Sprout can benefit from FDA's approval of another female sexual disorder drug American City Business Journals
Jun-24-19 05:45PM  AMAG's Vyleesi Gets FDA NOD for Women with Low Sexual Desire Zacks
04:19PM  Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women TheStreet.com
01:58PM  Another Womens Libido Drug, Vyleesi, Won FDA Approval. Stock Investors Arent Happy. Barrons.com
08:03AM  Palatin's stock rockets after FDA OK to market sexual desire disorder treatment MarketWatch
Jun-22-19 03:07PM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs Benzinga
Jun-21-19 05:41PM  AMAG stock rallies on FDA approval for drug to increase women's sex drive MarketWatch
05:37PM  Amags plan to bypass female libido drug pitfalls? Social media. American City Business Journals
05:23PM  AMAG Pharmaceuticals Announces FDA Approval of Vyleesi (Bremelanotide Injection) for Acquired, Generalized Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women GlobeNewswire
Jun-20-19 09:00AM  All You Need to Know About AMAG Pharmaceuticals (AMAG) Rating Upgrade to Buy Zacks
Jun-10-19 09:39AM  TherapeuticsMD Enters Agreement to Market Drugs Outside US Zacks
Jun-06-19 09:31AM  AMAG Pharmaceuticals (AMAG) Down 8.9% Since Last Earnings Report: Can It Rebound? Zacks
Jun-05-19 03:45PM  AMAG Pharmaceuticals Could Be Cut in Half Even From Here - Avoid TheStreet.com
May-29-19 08:00AM  AMAG Pharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference GlobeNewswire
May-20-19 03:15PM  Is AMAG Pharmaceuticals, Inc.'s (NASDAQ:AMAG) Balance Sheet A Threat To Its Future? Simply Wall St.
05:21AM  New Strong Sell Stocks for May 20th Zacks
May-17-19 08:00AM  AMAG Pharmaceuticals to Host Analyst Day on May 22, 2019 in New York GlobeNewswire
May-13-19 09:07PM  Edited Transcript of AMAG earnings conference call or presentation 7-May-19 12:00pm GMT Thomson Reuters StreetEvents
May-10-19 10:31AM  New Strong Sell Stocks for May 10th Zacks
May-09-19 07:48PM  Is AMAG Pharmaceuticals, Inc. (AMAG) A Good Stock To Buy? Insider Monkey
07:15PM  Amag Pharmaceuticals Inc (AMAG) President & CEO William K Heiden Bought $107,000 of Shares GuruFocus.com
06:57AM  AMAG Q1 Loss Wider Than Expected, Revenues Lag Estimates Zacks
May-08-19 07:53AM  The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split Benzinga +5.56%
May-07-19 01:23PM  AMAG Pharmaceuticals Inc (AMAG) Q1 2019 Earnings Call Transcript Motley Fool -12.28%
AMAG Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and commercializes therapeutics for maternal and women's health, anemia management, and cancer supportive care in the United States. It markets Feraheme (ferumoxytol), an intravenous iron replacement therapeutic agent for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron, as well as patients who have chronic kidney disease; Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women pregnant with a single baby who have a history of singleton spontaneous preterm birth; Intrarosa(prasterone) vaginal insert steroid for the treatment of dyspareunia due to menopause; and MuGard Mucoadhesive Oral Wound Rinse for the management of oral mucocitis/stomatiits and various types of oral wounds. The company's products candidates include Vyleesi (bremelanotide), an auto-injector device for the treatment of hypoactive sexual desire disorder in pre-menopausal women; AMAG-423, a polyclonal antibody in development for the treatment of severe preeclampsia in pregnant women; and Ciraparantag, an anticoagulant reversal agent for the treatment of oral anticoagulants or low molecular weight heparin. It sells Feraheme to authorized wholesalers and specialty distributors. The company has a license agreement with Endoceutics, Inc., Palatin Technologies, Inc., Velo Bio LLC, Perosphere Pharmaceuticals Inc., Antares Pharma, Inc., and Abeona Therapeutics, Inc. AMAG Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Camber Capital Management LP10% OwnerAug 09Buy8.9730,000268,9964,390,000Aug 09 03:41 PM
ARMISTICE CAPITAL, LLC10% OwnerAug 07Buy7.4340,000297,200240,000Aug 09 05:05 PM
ARMISTICE CAPITAL, LLC10% OwnerAug 07Buy7.32260,0001,903,2004,060,000Aug 09 05:05 PM
Camber Capital Management LP10% OwnerAug 07Buy7.78355,0002,760,7964,360,000Aug 09 03:41 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 27Buy9.4720,000189,400200,000Jun 27 06:29 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 27Buy9.5244,000418,8803,800,000Jun 27 06:29 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 26Buy9.13120,0001,095,6003,756,000Jun 27 06:29 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 25Buy8.8655,000487,050180,000Jun 27 06:29 PM
ARMISTICE CAPITAL, LLC10% OwnerJun 25Buy8.59259,0162,224,9473,636,000Jun 27 06:29 PM
Krop JulieChief Medical OfficerMay 28Buy9.9110,00099,10081,399May 29 04:27 PM
HEIDEN WILLIAM KPresident & CEOMay 09Buy10.7010,000107,000490,056May 09 04:16 PM
Bolgiano Elizabeth ScottChief Human Resources OfficerMay 09Buy10.935,00054,65074,847May 09 04:14 PM
Vittiglio JosephEVP, General CounselMar 07Sale14.011,42519,96478,955Mar 11 04:41 PM